ReachMD
Be part of the knowledge.™NeuroFrontiers
What to Consider When Treating Transgender Patients with Epilepsy
What to Consider When Treating Transgender Patients with Epilepsy
Diabetes Discourse
Diabetes & Dermatology: Uncovering Skin Conditions in Diabetic Patients
Diabetes & Dermatology: Uncovering Skin Conditions in Diabetic Patients
Diabetes Discourse
Investigating the Link Between Type 2 Diabetes & Obesity
Investigating the Link Between Type 2 Diabetes & Obesity
Diabetes Discourse
Hypoglycemia Risk Factors & Treatment Protocols: An Evaluation of Current ADA Guidelines
Hypoglycemia Risk Factors & Treatment Protocols: An Evaluation of Current ADA Guidelines
Diabetes Discourse
Recognizing the Pervasiveness of Hypoglycemia in Adults with T2D
Recognizing the Pervasiveness of Hypoglycemia in Adults with T2D
- 0
Diabetes Discourse
Keys to Minimizing Hypoglycemia Risk: A Look at HbA1c Management in Patients with T2D
Keys to Minimizing Hypoglycemia Risk: A Look at HbA1c Management in Patients with T2D
CME/CE
Clinicians' Update on Omega-3s in ASCVD Risk Reduction
Clinicians' Update on Omega-3s in ASCVD Risk Reduction
CME/CE
Changing Treatment Paradigms in Type 1 Diabetes: Role of Anti-CD3 Targeted Therapy -
Screening for Islet Autoantibodies in Children and Adolescents to Prevent/Delay T1D
Changing Treatment Paradigms in Type 1 Diabetes: Role of Anti-CD3 Targeted Therapy -
Screening for Islet Autoantibodies in Children and Adolescents to Prevent/Delay T1D
CME/CE
Changing Treatment Paradigms in Type 1 Diabetes: Role of Anti-CD3 Targeted Therapy -- Anti-CD3 Monoclonal Antibodies to Prevent/Delay Onset of Type 1 Diabetes
Changing Treatment Paradigms in Type 1 Diabetes: Role of Anti-CD3 Targeted Therapy -- Anti-CD3 Monoclonal Antibodies to Prevent/Delay Onset of Type 1 Diabetes
CME/CE
Understanding the Differences Between STRENGTH and REDUCE-IT Omega-3 Fatty Acid Clinical Trials and EPA/DHA
Understanding the Differences Between STRENGTH and REDUCE-IT Omega-3 Fatty Acid Clinical Trials and EPA/DHA
CME/CE
Frontiers in Diabetic Macular Edema: Addressing Health Disparities and Other Barriers to Optimal Outcomes
Frontiers in Diabetic Macular Edema: Addressing Health Disparities and Other Barriers to Optimal Outcomes
CME/CE
Optimizing Patient Outcomes in Acromegaly
Optimizing Patient Outcomes in Acromegaly
Medical Industry Feature
Case Studies Addressing Modern Care Challenges with Painful Diabetic Peripheral Neuropathy of the Feet
Case Studies Addressing Modern Care Challenges with Painful Diabetic Peripheral Neuropathy of the Feet
Medical Industry Feature
Capsaicin 8% Topical System: An Advancement in the Treatment of Painful Diabetic Peripheral Neuropathy of the Feet
Capsaicin 8% Topical System: An Advancement in the Treatment of Painful Diabetic Peripheral Neuropathy of the Feet
Medical Industry Feature
Addressing Questions Regarding Long-Term Treatment with a TPRV1 Agonist for Painful DPN of the Feet
Addressing Questions Regarding Long-Term Treatment with a TPRV1 Agonist for Painful DPN of the Feet
Medical Industry Feature
Best Practices for Administering Prescription Strength Capsaicin for Painful DPN of the Feet
Best Practices for Administering Prescription Strength Capsaicin for Painful DPN of the Feet
Medical Industry Feature
The CRM Systems and the Continuum of Disease Risk
The CRM Systems and the Continuum of Disease Risk
Medical Industry Feature
Morbidity of Cardio-Renal-Metabolic (CRM) Disorders: Multifaceted Risk Factor Management
Morbidity of Cardio-Renal-Metabolic (CRM) Disorders: Multifaceted Risk Factor Management
miragenews.com
10/20/2021- newswise.com
10/18/2021
- jagwire.augusta.edu
10/18/2021
- sciencedaily.com
10/15/2021
- medicalxpress.com
10/15/2021
- prnewswire.com
10/15/2021